Recent News

• 02.28.2025 - Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access
• 02.27.2025 - Employee Spotlight: Donald Rich
• 02.27.2025 - Penumbra Launches ACCESS25TM Delivery Microcatheter Designed for Aneurysm Access and Delivery of Elevated Clinical Benefits
• 02.24.2025 - Lightning BoltTM 7 Case Study: Restoring Flow to an Occluded Renal Artery with Computer Assisted Vacuum Thrombectomy (CAVTTM)
• 02.21.2025 - Penumbra, Inc. Announces Don Kassing will Retire from Board of Directors
• 02.20.2025 - MIND IDE Trial of Penumbra’s Artemis Neuro Evacuation Device Shows Potential Promise for Patients Experiencing Hemorrhagic Stroke
• 02.18.2025 - Penumbra, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Recent Filings

• 02.21.2025 - EX-99.1 EX-99.1
• 02.21.2025 - 8-K Current report
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.19.2025 - 4 Statement of changes in beneficial ownership of securities